ASCO 2019 ANNUAL MEETING

ASCO 2019 ANNUAL MEETING

INTERVIEW WITH EVAN YU
Management of mCRPC using Sipuleucel-T

VIEW ALL mCRPC VIDEOS

ASCO 2019 ANNUAL MEETING

ASCO 2019 ANNUAL MEETING

INTERVIEW WITH JACOB BERCHUCK & MARY-ELLEN TAPLIN
Genetic Risk in Prostate Cancer

VIEW ALL PROSTATE CANCER VIDEOS

ASCO 2019 ANNUAL MEETING

ASCO 2019 ANNUAL MEETING

INTERVIEW WITH KARIM FIZAZI
ARAMIS Trial in Prostate Cancer: Impact of Darolutamide on Pain and Quality of Life

VIEW ALL nmCRPC VIDEOS

EAU 2019 ANNUAL MEETING

EAU 2019 ANNUAL MEETING

INTERVIEW WITH THOMAS POWLES
Immunotherapy in the Peri-Operative Setting for Bladder Cancer

VIEW ALL BLADDER CANCER VIDEOS

Videos
State-of-the-industry video lectures by leading urology experts
Featured Videos

EAU 2014 - Poster: A phase 2 trial of prostate specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-refractory metastatic castration-resistant prostate cancer (mCRPC)

STOCKHOLM, SWEDEN (UroToday.com) - Presented by D Petrylak,1 D Smith,2 L Appleman,3 M Fleming,4 A Hussain,5 R Dreicer,6 AO Sartor,7 N Shore,8 NJ Vogelzang,9 H Youssoufian,10 VA DiPippo,10 N Stambler,10 K Huang,10 RJ Israel10 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.

Petrylak poster EAU 2014 thumb

 

1Yale University, New Haven, CT; 2University of Michigan, Ann Arbor, MI; 3University of Pittsburgh, Pittsburgh, PA; 4Virginia Oncology Associates, Norfolk, VA; 5University of Maryland, Baltimore, MD; 6Cleveland Clinic, Cleveland, OH; 7Tulane University, New Orleans, LA; 8Carolina Urologic Research Center, Myrtle Beach, SC; 9Comprehensive Cancer Centers of Nevada, Las Vegas, NV; 10Progenics Pharmaceuticals, Inc., Tarrytown, NY

 

Click HERE to listen to Daniel P. Petrylak, MD discuss the key points from this poster

 

 

Conference Coverage
 
Recent data from conferences worldwide
Journals
Publications focusing on urologic cancer treatments through original manuscripts
Everyday Urology Volume 4 Issue 1

Everyday Urology™ - Oncology Insights

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe